Determination of Salivary CD44 as a Noninvasive Diagnostic Biomarker to Predict Malignant Transformation of Oral Submucous Fibrosis
Our study was the first of its kind to assess the expression of CD44 in OSMF patients. Results infer that CD44 may decrease with the progression of normal mucosa to OSMF and with different grades, however, future studies are required with larger sample size to determine CD44 as molecular biomarker.
Authors
- Sukanya Ravindran (ORCID: https://orcid.org/0009-0002-6507-8098)
- Nalini Aswath (ORCID: https://orcid.org/0000-0001-6277-2493)
- Vijayalakshmi Ramshankar (ORCID: https://orcid.org/0000-0003-2464-0806)
- Rajalakshmi Rakshanaa
- K. Mehanathan
Institutions
- Cancer Institute (WIA) (IN)
- Sree Balaji Dental College and Hospital (IN)
- Bharath University (IN)
Publication Details
- Journal
- Contemporary Clinical Dentistry
- Published
- 2025-04-01
- DOI
- https://doi.org/10.4103/ccd.ccd_37_25
- Primary Topic
- Oral Health Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00